Full year production results and 2022 guidance. Compared to 2020, silver, and gold production in 2021 increased 38.6% and 13.8% to 4,870,787 ounces and 42,262 ounces, respectively. Strong full year operational performance was due, in part, to higher throughput and grades at the Guanacevi mine. At year-end, Endeavour held 1,028,340 ounces of silver and 1,044 ounces of gold bullion and 54,270 ounces of silver and 2,630 ounces of gold in concentrate inventory. In 2022, silver production is expected to range from 4.2 million to 4.8 million ounces, while gold production is expected to range from 31,000 to 35,000 ounces. Updating production and earnings estimates. We are updating our 2021 and 2022 EPS estimates to $(0.01) and $0.14 from $0.02 and $0.15, respectively. Our 2021 EBITDA estimates are $37.9 million and $65.9 million compared to our prior estimates of $44.8 million and $67.2 million, respectively. Our 2022 estimates reflect lower production, partially offset by sales from inventory, and a higher share count to reflect equity issuance related to the recently announced Pitarrilla acquisition. Fourth quarter earnings date. EXK will release fourth quarter 2021 financial results before the market open on March 10, 2022, and management will host a conference call for investors on the same day at 1:00 pm ET. We anticipate discussion to center on sources of future growth, including Terronera, Pitarrilla, and Parral. With respect to Terronera, once financing is in place, the board will approve construction which is expected to take 24 months with commercial production expected in the first half of 2024. Rating is Market Perform. We remain impressed with how the company's intermediate and long-term growth pipeline is developing. We think near-term risk and reward is balanced given steady production levels in 2022 and 2023 and a relatively high operating cost profile which could improve when Terronera goes into commercial production. Read More >>
January 20, 2022
News Provided by Channelchek via QuoteMedia
EDR:CA,EXK
INN Article Notification
The Conversation (0)
22h
Silver Institute: Sustained Supply Deficit Exposes Market to Squeezes
The global silver market is entering its sixth consecutive year of a supply deficit, but the underlying mechanics of the shortage have fundamentally shifted. According to the Silver Institute’s latest World Silver Survey, produced alongside London-based consultancy Metals Focus, the market will... Keep Reading...
02 April
Silver Price Update: Q1 2026 in Review
Silver achieved the hitherto unthinkable feat of triple-digit prices in the first quarter of 2026.The rise came as the silver market benefited from both expanding industrial uses and strong safe-haven demand. However, economic and geopolitical uncertainty brought about by the US-Iran war, as... Keep Reading...
01 April
Top 5 Canadian Silver Stocks in 2026
Silver achieved a triple-digit price in the first quarter of 2026, drawing attention to silver-mining companies.During January, the silver price reached an all-time high of US$121.62 per ounce. Although prices have come down significantly in recent weeks, silver remains well above its 40 year... Keep Reading...
25 March
Kinvestor Mining & Energy 2026 Virtual Investor Conference Agenda Announced for March 26, 2026
Kin Communications Inc. (“Kin”), Canada’s Leading Investor Relations Agency, is pleased to announce the agenda for the Kinvestor Mining & Energy Virtual Investor Conference taking place on Thursday, March 26, 2026. The event welcomes individual and institutional investors, financial advisors,... Keep Reading...
19 March
Silver X Secures US$50 Million to Expand Peru Project
Silver X Mining (TSXV:AGX,OTCQB:AGXPF) has tapped investor demand for exposure to the rising silver price, closing a US$50.4 million financing to fund expansion at its flagship project in Peru.It completed an oversubscribed brokered private placement of secured convertible debentures on... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00





